Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
Holding RCKT?
Track your performance easily
See the Price Targets and Ratings of:
RCKT Analyst Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RCKT Stock 12 Month Forecast
Average Price Target
$46.36
▲(285.69% Upside)
| Highest Price Target$65.00 | Average Price Target$46.36 | Lowest Price Target$29.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
12/11/24
LifeSci Capital
Reiterated
11/19/24
Bank of America Securities
Reiterated
11/19/24
TD Cowen
Reiterated
11/19/24
Scotiabank
Reiterated
11/19/24
Needham
Reiterated
11/19/24
Cantor Fitzgerald
Reiterated
11/18/24
J.P. Morgan
Reiterated
11/18/24
William Blair
Reiterated
11/18/24
Canaccord Genuity
Reiterated
11/18/24
Morgan Stanley
$45
Buy
274.38%
Upside
Reiterated
11/18/24
Rocket Pharmaceuticals' RP-A501 Shows Promising Long-Term Efficacy and Safety in Danon Disease Treatment: Buy Rating Affirmed
Goldman Sachs
$34→$29
Hold
141.26%
Upside
Reiterated
11/08/24
Rocket Pharmaceuticals (RCKT) PT Lowered to $29 at Goldman SachsGoldman Sachs analyst Richard Law lowered the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $29.00 (from $34.00) while maintaining a Neutral rating.
Stifel Nicolaus
$48
Buy
299.33%
Upside
Reiterated
11/08/24
Stifel Nicolaus Remains a Buy on Rocket Pharmaceuticals (RCKT)
UBS
$56→$54
Buy
349.25%
Upside
Reiterated
03/01/24
Rocket Pharmaceuticals (RCKT) PT Lowered to $54 at UBSUBS analyst Esther Rajavelu lowered the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $54.00 (from $56.00) while maintaining a Buy rating.
Best Analysts Covering Rocket Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy RCKT and Sell After:
1 Month
xxx
Success Rate
6/13 ratings generated profit
Average Return
-1.87%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.15% of your transactions generating a profit, with an average return of -1.87% per trade.
3 Months
xxx
Success Rate
6/13 ratings generated profit
Average Return
+3.28%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of +3.28% per trade.
1 Year
Success Rate
8/13 ratings generated profit
Average Return
+15.01%
reiterated a buy rating 30 days ago
Copying Greg Harrison's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +15.01% per trade.
2 Years
xxx
Success Rate
7/30 ratings generated profit
Average Return
-15.02%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.33% of your transactions generating a profit, with an average return of -15.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RCKT Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
13
13
13
23
19
Buy
6
6
6
7
5
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
20
20
31
25
Each month's total comprises the sum of three months' worth of ratings.
RCKT Financial Forecast
RCKT Stock Forecast FAQ
What is RCKT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rocket Pharmaceuticals’s 12-month average price target is $46.36.
What is RCKT’s upside potential, based on the analysts’ average price target?
Rocket Pharmaceuticals has 285.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RCKT a Buy, Sell or Hold?
Rocket Pharmaceuticals has a consensus rating of Strong Buy which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
What is Rocket Pharmaceuticals’s price target?
The average price target for Rocket Pharmaceuticals is $46.36. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $65.00 ,the lowest forecast is $29.00. The average price target represents 285.69% Increase from the current price of $12.02.
The highest analyst price target is $65.00 ,the lowest forecast is $29.00. The average price target represents 285.69% Increase from the current price of $12.02.
What do analysts say about Rocket Pharmaceuticals?
Rocket Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of RCKT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.